求助PDF
{"title":"首次使用溶瘤病毒疫苗的人体免疫治疗试验诱导大量颗粒淋巴细胞,后来被认为是“自然杀伤细胞”","authors":"J. Sinkovics","doi":"10.23937/2469-567X/1510049","DOIUrl":null,"url":null,"abstract":"Sinkovics. Int J Virol AIDS 2019, 6:049 • Page 1 of 4 • Citation: Sinkovics JG (2019) The First Human Immunotherapy Trial with a Viral Oncolysate Vaccine Induced a Large Number of Granular Lymphocytes Later Recognized as ‘Natural Killer Cells’. Int J Virol AIDS 6:049. doi.org/10.23937/2469-567X/1510049 Accepted: March 14, 2019: Published: March 16, 2019 Copyright: © 2019 Sinkovics JG. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. The First Human Immunotherapy Trial with a Viral Oncolysate Vaccine Induced a Large Number of Granular Lymphocytes Later Recognized as ‘Natural Killer Cells’","PeriodicalId":14458,"journal":{"name":"International Journal of Virology and AIDS","volume":"33 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"The First Human Immunotherapy Trial with a Viral Oncolysate Vaccine Induced a Large Number of Granular Lymphocytes Later Recognized as 'Natural Killer Cells'\",\"authors\":\"J. Sinkovics\",\"doi\":\"10.23937/2469-567X/1510049\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Sinkovics. Int J Virol AIDS 2019, 6:049 • Page 1 of 4 • Citation: Sinkovics JG (2019) The First Human Immunotherapy Trial with a Viral Oncolysate Vaccine Induced a Large Number of Granular Lymphocytes Later Recognized as ‘Natural Killer Cells’. Int J Virol AIDS 6:049. doi.org/10.23937/2469-567X/1510049 Accepted: March 14, 2019: Published: March 16, 2019 Copyright: © 2019 Sinkovics JG. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. The First Human Immunotherapy Trial with a Viral Oncolysate Vaccine Induced a Large Number of Granular Lymphocytes Later Recognized as ‘Natural Killer Cells’\",\"PeriodicalId\":14458,\"journal\":{\"name\":\"International Journal of Virology and AIDS\",\"volume\":\"33 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-03-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Virology and AIDS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.23937/2469-567X/1510049\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Virology and AIDS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/2469-567X/1510049","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
引用
批量引用
The First Human Immunotherapy Trial with a Viral Oncolysate Vaccine Induced a Large Number of Granular Lymphocytes Later Recognized as 'Natural Killer Cells'
Sinkovics. Int J Virol AIDS 2019, 6:049 • Page 1 of 4 • Citation: Sinkovics JG (2019) The First Human Immunotherapy Trial with a Viral Oncolysate Vaccine Induced a Large Number of Granular Lymphocytes Later Recognized as ‘Natural Killer Cells’. Int J Virol AIDS 6:049. doi.org/10.23937/2469-567X/1510049 Accepted: March 14, 2019: Published: March 16, 2019 Copyright: © 2019 Sinkovics JG. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. The First Human Immunotherapy Trial with a Viral Oncolysate Vaccine Induced a Large Number of Granular Lymphocytes Later Recognized as ‘Natural Killer Cells’